Medtronic develops and produces medical devices for cardiovascular care, diabetes management, spinal surgery, neurological treatment, and minimally invasive procedures. Its technologies include pacemakers, defibrillators, insulin pumps with continuous glucose monitoring, spinal implants, and surgical robots and navigation systems. Hospitals, physicians, and patients rely on these products for diagnosis, therapy, and long-term condition management.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q3 2025 | 8,578 | — | 1,040 | — |
| Q4 2025 | 8,961 | — | 1,374 | — |
| Q1 2026 | 9,017 | — | 1,143 | — |
| Q2 2026 | 9,807 | — | 1,244 | — |
| Q3 2026 | 9,756 | 13.7% | 1,470 | 41.4% |
All markets — KeepWinning global stock screener
Other companies on NYSE: CVS Health Corporation (CVS), McKesson Corporation (MCK), Phillips 66 (PSX), Bank of Montreal (BMO), Corning Incorporated (GLW), Stryker Corporation (SYK)